Evidence shows that semaglutide has the capacity to prevent age-related cognitive decline:
In mice models of Parkinson’s disease (PD), semaglutide produced significant neuroprotective and cognitive-enhancing effects.
In PD mouse models, semaglutide attenuated the effects of the disease by protecting the brain neurons against injury.